Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-03 Jacobs John C President and CEO Option exercise +150,167 264,130
2026-03-03 Jacobs John C President and CEO Shares withheld for taxes −69,288 $9.49 $658K 225,680
2026-03-03 Jacobs John C President and CEO Option exercise · Restricted Stock Units −150,167 300,333
2026-03-03 O'Hara Elaine EVP, Chief Strategy Officer Option exercise +56,334 157,071
2026-03-03 O'Hara Elaine EVP, Chief Strategy Officer Shares withheld for taxes −22,429 $9.49 $213K 134,642
2026-03-03 O'Hara Elaine EVP, Chief Strategy Officer Option exercise · Restricted Stock Units −56,334 112,666
2026-03-03 Casey Mark J EVP, Chief Legal Officer Option exercise +37,500 101,445
2026-03-03 Casey Mark J EVP, Chief Legal Officer Shares withheld for taxes −11,378 $9.49 $108K 90,067
2026-03-03 Casey Mark J EVP, Chief Legal Officer Option exercise · Restricted Stock Units −4,000 4,000
2026-03-03 Draghia-Akli Ruxandra EVP, Research & Development Option exercise +26,667 34,876
2026-03-03 Draghia-Akli Ruxandra EVP, Research & Development Shares withheld for taxes −11,313 $9.49 $107K 23,563
2026-03-03 Draghia-Akli Ruxandra EVP, Research & Development Returned to the company · Restricted Stock Units −26,667 53,333
2026-03-02 Kelly James Patrick EVP, CFO and Treasurer Grant or award · Non-statutory Stock Option NQ +194,000 194,000
2026-03-02 Draghia-Akli Ruxandra EVP, Research & Development Grant or award · Non-Statutory Stock Option NQ +139,500 139,500
2026-03-02 Casey Mark J EVP, Chief Legal Officer Grant or award · Non-Statutory Stock Option NQ +152,000 152,000
2026-03-02 Jacobs John C President and CEO Grant or award · Non-Statutory Stock Option NQ +551,500 551,500
2026-03-02 O'Hara Elaine EVP, Chief Strategy Officer Grant or award · 2026 Non-statutory Stock Option NQ +177,500 177,500
2026-03-02 Draghia-Akli Ruxandra EVP, Research & Development Grant or award · Restricted Stock Units +93,000 101,000
2026-03-02 Draghia-Akli Ruxandra EVP, Research & Development Grant or award · Non-Statutory Stock Opotion NQ +139,500 $9.09 $1.3M 139,500
2026-03-02 Jacobs John C President and CEO Grant or award · Restricted Stock Units +367,500 367,500

Page 3 of 14 · 279 trades